e-learning
resources
Paris 2018
Monday, 17.09.2018
State of the art session: Thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer and interstitial lung disease
J. Cadranel (Paris Cedex 20, France)
Source:
International Congress 2018 – State of the art session: Thoracic oncology
Session:
State of the art session: Thoracic oncology
Session type:
Symposium
Number:
1898
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Cadranel (Paris Cedex 20, France). Lung cancer and interstitial lung disease. International Congress 2018 – State of the art session: Thoracic oncology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Lung cancer in ILD
Source: ERS Course 2016
Year: 2016
Interstitial lung diseases and lung cancer
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Lung biopsy in the diagnostics of interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 561s
Year: 2007
Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019
Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018
Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019
Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012
Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014
Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014
Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015
Interstitial lung disease
Source: ERS Course 2015
Year: 2015
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016
Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006
Connective tissue disease-related interstitial lung disease and lung cancer
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept